NUVL · As filed with the SEC

Nuvalent income statement, by quarter

The statement as Nuvalent presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS · USD

USDQ1 2026
3 months ended Mar 31, 2026
Q4 2025
3 months ended Dec 31, 2025
Q3 2025
3 months ended Sep 30, 2025
Q2 2025
3 months ended Jun 30, 2025
Operating expenses:
Research and development83,608,000—83,843,00080,913,000
General and administrative35,799,000—28,853,00023,658,000
Total operating expenses119,407,000—112,696,000104,571,000
Loss from operations(119,407,000)—(112,696,000)(104,571,000)
Other income (expense)
Change in fair value of related party revenue share liability(2,570,000)—(19,810,000)(6,040,000)
Interest income and other income (expense), net12,866,000—10,201,00011,103,000
Total other income (expense), net10,296,000—(9,609,000)5,063,000
Loss before income taxes(109,111,000)—(122,305,000)(99,508,000)
Income tax provision168,000—132,000145,000
Net loss(109,279,000)—(122,437,000)(99,653,000)
Net loss per share attributable to Class A and Class B common stockholders, basic(1.39)—(1.7)(1.39)
Net loss per share attributable to Class A and Class B common stockholders, diluted(1.39)—(1.7)(1.39)
Weighted average shares of Class A and Class B common stock outstanding, basic78,670,371—72,143,46671,843,774
Weighted average shares of Class A and Class B common stock outstanding, diluted78,670,371—72,143,46671,843,774
Comprehensive loss:
Net loss(109,279,000)—(122,437,000)(99,653,000)
Other comprehensive income (loss)
Unrealized gains (losses) on marketable securities(3,708,000)—1,007,000509,000
Comprehensive loss(112,987,000)—(121,430,000)(99,144,000)

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.